Literature DB >> 21311905

Genetic variation in caspase-1 as predictor of accelerated progression from mild cognitive impairment to Alzheimer's disease.

Ana Pozueta, José Luis Vázquez-Higuera, Pascual Sánchez-Juan, Eloy Rodríguez-Rodríguez, Coro Sánchez-Quintana, Ignacio Mateo, José Berciano, Onofre Combarros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21311905     DOI： 10.1007/s00415-011-5935-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Caspase-1 genetic variation is not associated with Alzheimer's disease risk.

Authors:  José Luis Vázquez-Higuera; Eloy Rodríguez-Rodríguez; Pascual Sánchez-Juan; Ignacio Mateo; Ana Pozueta; Ana Martínez-García; Ana Frank; Fernando Valdivieso; José Berciano; María J Bullido; Onofre Combarros
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

2.  Comparing predictors of conversion and decline in mild cognitive impairment.

Authors:  S M Landau; D Harvey; C M Madison; E M Reiman; N L Foster; P S Aisen; R C Petersen; L M Shaw; J Q Trojanowski; C R Jack; M W Weiner; W J Jagust
Journal:  Neurology       Date:  2010-06-30       Impact factor: 9.910

Review 3.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

4.  APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.

Authors:  A Barabash; A Marcos; I Ancín; B Vázquez-Alvarez; C de Ugarte; P Gil; C Fernández; M Encinas; J J López-Ibor; J A Cabranes
Journal:  Neurobiol Aging       Date:  2007-12-19       Impact factor: 4.673

Review 5.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study.

Authors:  S Trompet; A J M de Craen; P Slagboom; J Shepherd; G J Blauw; M B Murphy; E L E M Bollen; B M Buckley; I Ford; A Gaw; P W Macfarlane; C J Packard; D J Stott; J W Jukema; R G J Westendorp
Journal:  Brain       Date:  2008-02-26       Impact factor: 13.501
  6 in total
  7 in total

1.  The NLRP3 and CASP1 gene polymorphisms are associated with developing of acute coronary syndrome: a case-control study.

Authors:  Hector Gonzalez-Pacheco; Gilberto Vargas-Alarcon; Javier Angeles-Martinez; Carlos Martinez-Sanchez; Oscar Perez-Mendez; Gabriel Herrera-Maya; Marco Antonio Martinez-Rios; Marco Antonio Peña-Duque; Carlos Posadas-Romero; Jose Manuel Fragoso
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 2.  Dementia and behavioral neurology: recent advances.

Authors:  Basar Bilgic; Hasmet A Hanagasi; Murat Emre
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

3.  Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment.

Authors:  Joseph Flores; Anastasia Noël; Marie-Lyne Fillion; Andréa C LeBlanc
Journal:  Cell Death Differ       Date:  2021-10-08       Impact factor: 12.067

4.  Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.

Authors:  E Rodríguez-Rodríguez; P Sánchez-Juan; J L Vázquez-Higuera; I Mateo; A Pozueta; J Berciano; S Cervantes; D Alcolea; P Martínez-Lage; J Clarimón; A Lleó; P Pastor; O Combarros
Journal:  J Neural Transm (Vienna)       Date:  2012-11-20       Impact factor: 3.575

5.  Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort.

Authors:  Yi Liu; Meng-Shan Tan; Zuo-Teng Wang; Wei Xu; Lan Tan
Journal:  BMC Neurol       Date:  2022-02-16       Impact factor: 2.903

6.  CASP1 Gene Polymorphisms and BAT1-NFKBIL-LTA-CASP1 Gene-Gene Interactions Are Associated with Restenosis after Coronary Stenting.

Authors:  Gilberto Vargas-Alarcón; Julian Ramírez-Bello; Marco Antonio Peña-Duque; Marco Antonio Martínez-Ríos; Hilda Delgadillo-Rodríguez; José Manuel Fragoso
Journal:  Biomolecules       Date:  2022-05-31

7.  Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model.

Authors:  Joseph Flores; Anastasia Noël; Bénédicte Foveau; Jeffrey Lynham; Clotilde Lecrux; Andréa C LeBlanc
Journal:  Nat Commun       Date:  2018-09-25       Impact factor: 14.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.